Core Viewpoint - The Jiangsu Free Trade Zone has launched a comprehensive reform plan for the biopharmaceutical industry, aiming to enhance innovation, reduce costs, and streamline processes, thereby positioning Jiangsu as a leader in the biopharmaceutical sector in China [3][4]. Group 1: Reform Characteristics - The reform plan is characterized by its originality and integrative nature, being the first in the nation to propose an open innovation development for the entire biopharmaceutical industry chain [3]. - Jiangsu is the first province approved for a pilot program in the biopharmaceutical sector and the first to receive a national special plan since the establishment of the Jiangsu Free Trade Zone [3]. Group 2: Policy Implementation - The implementation plan includes 18 measures across six areas: enhancing R&D capabilities, improving product approval services, building a production and distribution system, refining procurement policies, increasing support for resources, and ensuring safety in development [3]. - The focus is on the entire chain from R&D to manufacturing, distribution, and usage, aiming for breakthroughs across all paths [4]. Group 3: Industry Strengths - Jiangsu accounts for one-eighth of the national biopharmaceutical industry, ranking first in terms of scale [4]. - The province leads in the number of innovative drugs approved for market, with approximately one-third of the national total [4]. - The Free Trade Zone's three areas contribute significantly to the industry, showcasing strong upstream and downstream capabilities [4]. Group 4: Process Improvements - The reform aims to expedite the research and approval processes for generic drugs, with plans for a pilot program to simplify the registration process [4]. - New policies will allow segmented production, potentially reducing fixed asset investments by about 30% for biopharmaceutical companies [4]. Group 5: International Collaboration - The plan facilitates the recognition of international professional qualifications for foreign experts, allowing them to work in Jiangsu without needing to pass domestic qualification exams [5]. - It encourages foreign physicians to provide short-term medical services within the Free Trade Zone, enhancing local access to international expertise [5].
让好药研得快、减成本、通关快、用得快,在江苏自贸试验区,就有机会挂到外籍专家号
Yang Zi Wan Bao Wang·2025-09-16 11:34